OOIR: Observatory of International Research

Papers

(The TQCC of Transfusion Medicine is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)

Article	Citations
Convalescent plasma therapy for the treatment of patients with COVID‐19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels	52
Impact of COVID‐19 in the attendance of blood donors and production on a Brazilian Blood Centres	19
Clinical Implication of Immunohaematological Tests in ABO haemolytic disease of newborn: Revisiting an old disease	15
Effect of convalescent plasma as complementary treatment in patients with moderate COVID‐19 infection	15
Comparison of four methods to measure haemoglobin concentrations in whole blood donors (COMPARE): A diagnostic accuracy study	13
Practical approach to transfusion management of post‐partum haemorrhage	12
Trust and distrust: Identifying recruitment targets for ethnic minority blood donors	11
Machine learning for predicting preoperative red blood cell demand	11
Behaviour based screening questions and potential donation loss using the “for the assessment of individualised risk” screening criteria: A Canadian perspective	11
Effect of leukoreduction on transfusion‐related immunomodulation in patients undergoing cardiac surgery	11
Erythropoiesis‐stimulating agents as replacement therapy for blood transfusions in critically ill patients with anaemia: A systematic review with meta‐analysis	11
Absence of SARS‐CoV‐2 viraemia in a blood donor with COVID‐19 post‐donation	11
Systematic review and meta‐analysis of randomised controlled trials testing the safety and efficacy of convalescent plasma in the treatment of coronavirus disease 2019 (COVID‐19): Evidence‐	10
Hydrops fetalis associated with anti‐CD36 antibodies in fetal and neonatal alloimmune thrombocytopenia: Possible underlying mechanism	10
Adherence to blood product transfusion guidelines—An observational study of the current transfusion practice in a medical intensive care unit	10
Motivators of and barriers to becoming a COVID‐19 convalescent plasma donor: A survey study	10
Evaluating the risk of transfusion and transplant‐transmitted monkeypox infections	9
The Norwegian experience with nationwide implementation of fetal RHD genotyping and targeted routine antenatal anti‐D prophylaxis	9
Inter‐donor variability in deformability of red blood cells in blood units	9
Massive transfusion protocols in paediatric trauma population: A systematic review	9
A review of whole‐blood donors' willingness, motives, barriers and interventions related to donating another substance of human origin	8
Risk of hepatitis‐E virus infections among blood donors in a regional blood transfusion centre in western India	8
E‐learning/online education in transfusion medicine: A cross‐sectional international survey	8
Effect of the first year of COVID‐19 pandemic on the collection and use of blood components in Colombia monitored through the national haemovigilance system	7
Deterrents in recruitment of COVID‐19 convalescent plasma donors: Experience from a hospital‐based blood centre in India	7

Convalescent plasma and COVID‐19: Time for a second—second look?	7
Development and validation of a nomogram to predict intraoperative blood transfusion for gastric cancer surgery	7
Beyond COVID‐19 and lessons learned in the United States	7
Safety and efficacy of COVID‐19 convalescent plasma in severe pulmonary disease: A report of 17 patients	7
Fertility and pregnancy in Iranian thalassemia patients: An update on transfusion complications	6
Effect of patient blood management system and feedback programme on appropriateness of transfusion: An experience of Asia's first Bloodless Medicine Center on a hospital basis	6
Pulmonary complications of transfusion: Changes, challenges, and future directions	6
A UK national survey of prophylactic platelet transfusion thresholds in non‐bleeding, critically ill adults	6
Prophylactic tranexamic acid use in non‐cardiac surgeries at high risk for transfusion	6
Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction	6
Transfusion in critical care: Past, present and future	6
Association between the length of storage of transfused leukoreduced red blood cell units and hospital‐acquired infections in critically ill children: A secondary analysis of the TRIPICU st	6
Alloimmunisation rate of patients on Daratumumab: A retrospective cohort study of patients in England	6
Importation of plasma and use of apheresis platelets as risk reduction measures for variant Creutzfeldt‐Jakob disease: The SaBTO review	5
Transfusion therapy of neonatal and paediatric patients: They are not just little adults	5
Transfusion 2024: A 5‐year plan for clinical and laboratory transfusion in England	5
Assessment the knowledge of blood transfusion in Iranian nurses of Tehran's hospitals	5
Histo‐blood group A is a risk factor for severe COVID‐19	5
Salvage of refractory post‐transfusion hyperhaemolysis by targeting hyperinflammation and macrophage activation with tocilizumab	5
Mapping anticipated advantages and disadvantages of implementation of extensive donor genotyping: A focus group approach	5
Impact of Covid‐19 epidemic on the activities of a blood centre, transfusion support for infected patients and clinical outcomes	5
Extended red blood cell matching for all transfusion recipients is feasible	5
Monitoring iron stores in Icelandic blood donors from 1997 through 2019	5
Sickle cell disease patients in two London trusts: Genotyping including RH variants	5
ABO‐incompatible convalescent plasma transfusion: Yes, you can	4
Detection frequencies and viral load distribution of parvovirus B19 DNA in blood and plasma donations in England	4
Skin flora and bacterial contamination of diversion pouch and recovered platelet components in Moroccan blood donors	4
The haemoglobinopathy survey: The reality of transfusion practice in sickle cell disease and thalassaemia in England	4
Convalescent plasma for COVID‐19: Donor demographic factors associated high neutralising antibody titres	4
Recovery of platelet‐rich red blood cells and acquisition of convalescent plasma with a novel gravity‐driven blood separation device	4
Red blood cell transfusion in myelodysplastic syndromes: A systematic review	4
Systematic review of prevalence and risk factors of transfusion transmissible infections among blood donors, and blood safety improvements in Southern Africa	4
Improving blood‐prescribing decisions: Evaluating the efficacy of a blood guidelines app	4
Screening of at‐risk blood donors for Chagas disease in non‐endemic countries: Lessons from a 2‐year experience in Tuscany, Italy	4
Comparative analysis of hepatitis B virus infections in blood donors born before and after the implementation of universal HBV vaccination in southern China	4
Role of ABO blood system in COVID‐19: Findings from a southern Italian study	4
Probable cefepime‐induced immune mediated hemolytic anaemia	4
Passenger lymphocyte syndrome with severe haemolysis misdiagnosed/treated as cold agglutinin syndrome: Analysis of case and diagnostic error	4
Quantitative increases of extracellular vesicles in prolonged cold storage of platelets increases the potential to enhance fibrin clot formation	4
Blood group P1 prediction using multiplex PCR genotyping of A4GALT among Thai blood donors	3
Emergency response to COVID‐19 epidemic: One Chinese blood centre's experience	3
Plasma pooling in combination with amotosalen/UVA pathogen inactivation to increase standardisation and safety of therapeutic plasma units	3
Transfusion requirement prediction score for patients undergoing cardiac surgery: An experience from a tertiary care set‐up from South India	3
Utility of pre‐operative haemoglobin concentration to guide peri‐operative blood tests for hip and knee arthroplasty: A decision curve analysis	3
Poster session	3
London 2017: Lessons learned in transfusion emergency planning	3
Impact of microbial contamination of haematopoietic stem cells on post‐transplant outcomes: A retrospective study from tertiary care centre in India	3
The use of prothrombin complex concentrate in chronic liver disease: A review of the literature	3
Anti‐HBc and hepatitis B virus DNA among HBsAg‐negative blood donors from the main central blood bank units in Eastern Libya	3
Detection and analysis of blood donors seropositive for syphilis	3

Pain control and functional improvement in patients treated by autologous conditioned serum after failure of platelet rich plasma treatments in knee osteoarthritis	3
Prospective audit of blood transfusion request forms and continuing medical education to optimise compliance of clinicians in a hospital setting	3
A physiology‐based trigger score to guide perioperative transfusion of allogeneic red blood cells: A multicentre randomised controlled trial	3
The contribution and potential of older blood donors in Asia Pacific regions	3
Kinetics of anti‐SARS‐COV2 spike protein IgG and IgA antibodies at 4°C: Implications for convalescent plasma stability	3
The lack of anti‐PF4 antibodies in convalescent plasma from COVID‐19 infected blood donor	3
Hepatitis C virus screening reactive among blood donors in mainland China: A systematic review and meta‐analysis	3
Patterns of paediatric massive blood transfusion protocol use in trauma and non‐trauma patients	3
Confirmed non‐invasive prenatal testing for foetal Rh blood group genotyping along with bi‐allelic short insertion/deletion polymorphisms as a positive internal control	3
Randomised controlled trial of glucose‐6‐phosphate dehydrogenase deficient versus non‐deficient red blood cell transfusion in patients with hypoproliferative anaemia	2
A case of hyperhaemolysis syndrome in a pregnant Chinese woman with β‐thalassemia during perinatal transfusion	2
Demographic, clinical, and biochemical predictors of pica in high‐intensity blood donors	2
ABO(H) and Lewis blood group substances and disease treatment	2
Paroxysmal cold hemoglobinuria: A diagnostic dilemma in a paediatric patient	2
Divergence in phenotyping and genotyping analysis of the Lewis histo‐blood group system	2
The ongoing dilemma of prophylactic platelet transfusions pre‐procedure and the development of evidence‐based recommendations	2
Blood collection failures from a blood establishment perspective	2
The CRYOSTAT2 trial: The rationale and study protocol for a multi‐Centre, randomised, controlled trial evaluating the effects of early high‐dose cryoprecipitate in adult patients with major	2
HLA‐DRB1 and cytokine polymorphisms in Brazilian patients with myelodysplastic syndromes and its association with red blood cell alloimmunization	2
Validation of an apoptosis assay for extracorporeal photopheresis	2
Re‐examine the transfusion transmitted risk of SARS‐CoV‐2 virus during a major COVID‐19 outbreak in 2022	2
Effects of cryopreservation on gram‐positive bacteria contaminants in umbilical cord blood	2
A survey of nurses to assess transfusion practice at the bedside using an electronic identification system: Experience at a university hospital	2
Impact of the use of hydroxyethyl starch in granulocyte apheresis using Spectra Optia	2
D variants in the population of D‐negative blood donors in the north‐eastern region of Croatia	2
Efficacy of octreotide in the treatment of gastrointestinal angiodysplasia in a patient with Glanzmann thrombasthenia	2
Anaphylactic reaction after pre‐deposit autologous blood transfusion	2
Prevalence of anaemia in patients discharged from the paediatric intensive care unit	2
Prevalence of leucocyte antibodies in non‐transfused male and female platelet apheresis donors	2
Higher levels of von Willebrand factor in hospitalised patient plasma provides an explanation for the association of ABO blood group and secretor status with COVID19 severity	2
Low‐titer group O whole blood in military ground ambulances: Lessons from the Israel Defense Forces initial experience	2
A systematic review of the safety and efficacy of convalescent plasma or immunoglobulin treatment for people with severe respiratory viral infections due to coronaviruses or influenza	2
Implementation of an anaemia walk‐in clinic: Feasibility and preliminary data from the Orthopedic University Hospital	2
Role of donor self‐reporting in securing blood safety during COVID‐19 pandemic	2
Motivations for blood donation by HIV‐positive individuals on antiretrovirals in South Africa: A qualitative study	2
Splanchnic‐cerebral oxygenation ratio associated with packed red blood cell transfusion in preterm infants	2
A prospective interventional study to assess the impact of a ‘structured compact training’ on knowledge and skills of safe blood transfusion practices among nurses working in a tertiary care institute	2
D‐‐phenotype due to RHD‐RHCE hybrid transcript in a case of severe haemolytic disease of newborn with anti‐Rh 17(Hrₒ) antibodies	2
Serological screening and genetic analysis ofRhCEvariants in the Chinese Southern Han donors	2
The central blood volume as measured by thoracic electrical impedance and plasma proANP is not compromised by donation of 900 mL of blood in men	2
BGvar: A comprehensive resource for blood group immunogenetics	2
Effects of storage on quality and function of acid‐treated platelets with reduced HLA Class I surface expression	2
Diagnostic accuracy of Abbott Architect Assay as a screening tool for human T‐cell leukaemia virus type‐1 and type‐2 infection in a London teaching hospital with a large solid organ transplant centre	2